Skip to main content
ArticleOPEN ACCESS

Response to comment on ’Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity’

eLife
DOI: 10.7554/eLife.43928
4Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

We respond to concerns expressed by Pacifici and Shore (2019) about a recent paper (Lees-Shepard and Goldhamer, 2018a) in which we reported that the drug palovarotene can have severe side effects in a mouse model of fibrodysplasia ossificans progressiva.

Cite

CITATION STYLE

APA

Goldhamer, D. J., & Lees-Shepard, J. B. (2019). Response to comment on ’Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity’. ELife. eLife Sciences Publications Ltd. https://doi.org/10.7554/eLife.43928

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free